Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06156215 · ClinicalTrials.gov registry record · NA
PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 919
- Enrollment target
NCT06156215 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 919 participants.
The verdict
NCT06156215, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 919 participants
- Enrollment target
Study Summary
The goal of this cluster randomized clinical trial is to test the efficacy of messaging interventions to increase booster vaccine uptake in adults in the emergency department(ED). The main question\[s\] and goals of this study are: * does the intervention of vaccine messaging increase booster vaccine uptake at 30 days post ED visit? * does the intervention of asking about vaccine acceptance increase booster vaccine uptake at 30 days post ED visit? * considering recent national changes to funding and availability of updated vaccines, the investigators will examine the effects of these changes on vaccine acceptance and uptake in ED populations. Specifically, they will stratify EDs and ED patients according to the ED availability of vaccines, and they will also examine whether costs and availability of vaccines are a deterrent to patient acceptance and uptake of vaccines
Interventions
- BEHAVIORAL Vaccine Messaging
- BEHAVIORAL Vaccine Acceptance Question
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 919 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2024-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06156215
The ClinicalTrials.gov registry entry for NCT06156215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 919 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaccine Messaging is the first listed.
NCT06156215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06156215 about?
NCT06156215 is a clinical study titled "PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED". The goal of this cluster randomized clinical trial is to test the efficacy of messaging interventions to increase booster vaccine uptake in adults in the emergency department(ED). The main question\[s\] and goals of this study are: * does the intervention of vaccine messaging increase booster vacci...
What is the current status of trial NCT06156215?
This trial is currently completed. It is a NA study. The enrollment target is 919 participants. The study started on 2024-01-19. Estimated completion is 2024-08-18.
What interventions are being tested in trial NCT06156215?
The interventions under investigation include: Vaccine Messaging (BEHAVIORAL), Vaccine Acceptance Question (BEHAVIORAL).
Who is sponsoring clinical trial NCT06156215?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.